Onconetix, Inc.
ONCO
$0.94
-$0.01-1.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -78.84% | -57.36% | -25.36% | -84.89% | -85.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.84% | -57.36% | -25.36% | -84.89% | -85.49% |
| Cost of Revenue | -58.60% | 7.50% | -88.45% | -94.04% | -89.09% |
| Gross Profit | -103.71% | -62.47% | 155.12% | -29.99% | -75.77% |
| SG&A Expenses | 21.81% | -42.83% | -11.38% | -31.41% | -55.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.45% | -40.95% | -22.27% | -48.69% | -59.17% |
| Operating Income | -26.56% | 35.02% | 21.80% | 36.63% | 54.04% |
| Income Before Tax | 50.68% | 118.68% | -126.16% | 83.36% | 23.97% |
| Income Tax Expenses | -- | 100.05% | -- | -- | -- |
| Earnings from Continuing Operations | 50.68% | 119.26% | -129.50% | 83.42% | 23.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.68% | 119.26% | -129.50% | 83.42% | 23.14% |
| EBIT | -26.56% | 35.02% | 21.80% | 36.63% | 54.04% |
| EBITDA | -26.59% | 31.02% | 15.39% | 30.17% | 51.38% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |